287 related articles for article (PubMed ID: 34581026)
21. Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.
Mao C; Gao Y; Wan M; Xu N
Funct Integr Genomics; 2022 Aug; 22(4):597-609. PubMed ID: 35420332
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments.
Zhang M; Zhang F; Wang J; Liang Q; Zhou W; Liu J
J Transl Med; 2024 May; 22(1):423. PubMed ID: 38704606
[TBL] [Abstract][Full Text] [Related]
24. Development of the expression and prognostic significance of m
Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
[TBL] [Abstract][Full Text] [Related]
25. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
26. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
Ma W; Zhong M; Liu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
[TBL] [Abstract][Full Text] [Related]
27. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy.
Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114
[TBL] [Abstract][Full Text] [Related]
28. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
30. Identification of an eight-lncRNA prognostic model for breast cancer using WGCNA network analysis and a Cox‑proportional hazards model based on L1-penalized estimation.
Liu Z; Li M; Hua Q; Li Y; Wang G
Int J Mol Med; 2019 Oct; 44(4):1333-1343. PubMed ID: 31432096
[TBL] [Abstract][Full Text] [Related]
31. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.
Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ
Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112
[TBL] [Abstract][Full Text] [Related]
32. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
33. A four-long non-coding RNA signature in predicting breast cancer survival.
Meng J; Li P; Zhang Q; Yang Z; Fu S
J Exp Clin Cancer Res; 2014 Oct; 33(1):84. PubMed ID: 25288503
[TBL] [Abstract][Full Text] [Related]
34. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer.
Zhang Y; Zhou H; Zhang M; Xing L; Yang C; Xia B; Lou G
Aging (Albany NY); 2020 Nov; 12(24):25153-25171. PubMed ID: 33223503
[TBL] [Abstract][Full Text] [Related]
36. The nomogram based on the 6-lncRNA model can promote the prognosis prediction of patients with breast invasive carcinoma.
Luo D; Yao W; Wang Q; Yang Q; Liu X; Yang Y; Zhang W; Xue D; Ma B
Sci Rep; 2021 Oct; 11(1):20863. PubMed ID: 34675301
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX
Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257
[TBL] [Abstract][Full Text] [Related]
38. Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer.
Li J; Wang W; Xia P; Wan L; Zhang L; Yu L; Wang L; Chen X; Xiao Y; Xu C
Int J Cancer; 2018 Nov; 143(9):2150-2160. PubMed ID: 29707762
[TBL] [Abstract][Full Text] [Related]
39. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]